CNAB Cannabinoid Research & Development (CRD), subsidiary of United Cannabis, is a Jamaican based corporation pursuing local licensing to advance the use of medical cannabis therapies through biomedical research and development for the nutraceutical industry. The company focuses on genetic restoration, cannabinoid isolation techniques, scientific research, educational programs, and promotes domestic job opportunities. The company is pioneered by Marcus Richardson, a cannabis veteran from Canada with over 20 years of resin isolation experience, and backed by Jamaican partners specializing in agricultural science and plant based medicine. John Sayers, a local Jamaican director of CRD, will help United Cannabis implement his 40 years of agricultural methodologies into localized educational curriculums, job training programs, and help with integration of localized products.